<DOC>
	<DOCNO>NCT00956709</DOCNO>
	<brief_summary>Ropivacaine 0.5 % 0.5 % levobupivacaïne use regional anesthesia major surgery foot . The literature highlight significant difference term onset action two molecule block sciatic nerve [ 4 ] . Our hypothesis lack difference due use neurostimulator locate injection site ( indiscriminate nature anatomical approach sciatic nerve ) . Indeed , sensitivity neurostimulation low compare ultrasound [ 58 ] ultrasound , accurate visualization deposit local anesthetic around nerve improve quality block reduce onset action local anesthetic [ 46 , 47 ] . The investigator propose make comparative trial levobupivacaïne 0.5 % ropivacaine 0.5 % control ultrasound part sciatic nerve block . The use ultrasound reduce variability result change would link exclusively local anesthetic . The investigator test hypothesis levobupivacaïne give good result term onset action ropivacaine .</brief_summary>
	<brief_title>Regional Anesthesia Major Surgery Foot . Levobupivacaïne Ropivacaine 0.5 % Versus 0.5 % Sciatic Block Through médiofémorale</brief_title>
	<detailed_description />
	<mesh_term>Ropivacaine</mesh_term>
	<mesh_term>Levobupivacaine</mesh_term>
	<mesh_term>Bupivacaine</mesh_term>
	<criteria>Patients unilateral major surgery foot : hallux valgus ( ambulatory ) , claw toe , fusionAstragalo calcaneum , complex synthesis tarsusaged 18 year . Male female ASA 1 2 Insured Social Informed Consent Diabetes Intoxicationalcoholic chronic Allergy local anesthetic Hemostasis disorder Hepatic failure Chronic pain syndrome</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>